EA Pharma News and Activities
Presence
Headquarters: Japan
Eisai is one of the...
Eisai is a company listed under the stock ticker 4523 (JP).
Eisai has a direct presence in 11 countries.Eisai has 12 subsidiaries including EA Pharma, Eisai Americas and Eisai Australia.
They are in:
Executives
View the org chart displaying its 10 main executives
Most searched biographies at EA Pharma
- Hidenori Yabune, Representative Director, President & Chief Execut...
- Takashi Shibano, Senior Vice President
- Shigeki Honda, Senior Vice President
Popular executive movements at Eisai
- Akiko Nakahama who was Vice President, Chief Portfolio Officer, Asia Filing and Registration, Chief Quality Officer and Japan Regulatory Affairs, becomes Vice President Manufacturing, Quality and Technology, (posted on April 28 2026).
- Terushige Iike who was Executive Vice President, Chief Strategy and Planning Officer, becomes Executive Vice President Chief Business Officer, Internal Audit (posted on April 28 2026).
Create your alert
to follow the executive moves at EA Pharma.
Pharmaceuticals
Eisai has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- Novartis has announced the acquisition of Myricx Bio (posted on July 6 2026).
- Ipsen has announced the acquisition of Kartos Therapeutics (posted on July 3 2026).
- Ipsen has announced the acquisition of Memo Therapeutics (posted on July 1 2026).
Popular contacts in Pharmaceuticals
News
Press releases by EA Pharma
Social media about EA Pharma
- EA Pharma on Wikipedia, Google News & Yahoo Finance
- EA Pharma on LinkedIn, X (Twitter) & YouTube
